Ioannis T Virlos, H Priyantha Siriwardana, Yeliz Cemal, Ajith K Siriwardena
Objective This study examines clinical management pathways for patients with suspected pancreatic cancer within a singleUnited Kingdom Calman-Hine NHS cancer network with particular focus on referral patterns and the primary care-hospitalspecialist interface. Methods A questionnaire-based study appraising responses from three key groups (general practitioners, gastrointestinal physicians and gastrointestinal surgeons) practising within a cancer network. The questionnaire addressed caseload, referral pathways, multidisciplinary care teams and involvement of specialists. Participants The study population comprised 448 general practitioners, 14 gastroenterologists and 23 gastrointestinal surgeons. Results The mean number of new patients with suspected pancreatic cancer seen per general practitioner per annum was 0.4 (range: 0-1). Fifty-three percent of general practitioners refer to gastrointestinal physicians and 47% to gastrointestinal surgeons. In hospital, a relatively large number of physicians and surgeons see a small number of new patients each per annum. The involvement of multidisciplinary teams and referral of patients with nonresectable disease for chemotherapy is limited. Fourteen (60.9% out of 23 general surgeons) refer all patients to pancreatic specialists, 4 (17.4%) selectively refer and 5 (21.7%) never refer. Conclusion The findings suggest divergence in standards of care from those advocated in governmental cancer strategic plans. In particular, not all patients with suspected pancreatic cancer see specialists, many hospital specialists see small numbers of cases and multidisciplinary care is limited.
